查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球外科粘合剂市场-2022-2029
市场调查报告书
商品编码
1140708

全球外科粘合剂市场-2022-2029

Global Surgical Glue Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

外科粘合剂市场规模预计将在 2021 年达到 52.8 亿美元，在 2029 年达到 91.3 亿美元，在预测期间（2022-2029 年）以 7.64% 的复合年增长率增长。

手术胶（也称为手术密封剂或粘合剂）用于在手术或创伤后将外部和内部组织固定在一起。手术粘合剂可以与缝合线和钉书钉结合使用或作为其替代品。它使用化学键将组织固定在一起以进行癒合或充当阻止体液流动的屏障。外科粘合剂市场的进步主要是为了解决传统伤口闭合技术的局限性。此外，由于手术粘合剂具有良好的生物学和物理特性，越来越多的外科医生正在使用这种技术来密封伤口。外科胶水来源于几种天然生物聚合物，如明胶、胶原蛋白、壳聚醣、白蛋白和纤维蛋白。

市场动态

市场的增长受到各种因素的推动，例如外科手术和烧伤数量的增加、全球道路交通事故发生率的增加以及健康意识的提高。

预计手术数量增加和创伤增加将推动市场增长。

创伤的增加将使市场活跃起来。此外，全球外科手术和烧伤数量的增加以及交通事故数量的增加是市场增长的主要驱动力。健康意识的提高和疾病（如皮肤病、癌症、心脏病和呼吸系统疾病）的高发病率正在增加手术干预的机会。

根据世界卫生组织（WHO）2020年报告，估计每年约有135万人死于交通事故。还估计有 20-5000 万人遭受非致命伤害，其中许多人因受伤致残。世界上 93% 的道路死亡事故发生在低收入和中等收入国家，儘管他们占世界汽车总数的 60%。即使在高收入国家，社会经济背景较低的人也更有可能捲入交通事故。因此，预计疾病流行率的增加以及道路伤害案件将推动市场。

此外，这些设备在全球范围内具有无数的可访问性和可用性，这是外科粘合剂市场增长的主要原因之一。由于可支配收入的增加和这些国家居民的健康问题日益严重，发达国家和发展中国家的公民都在医疗保健服务上进行了大量支出。

美国疾病控制与预防中心 (CDC) 最近发布的一项研究表明，美国医疗保健服务的总支出预计将达到 3.9 万亿美元。英国国家统计局 (ONS) 的一份报告发现，过去英国的医疗保健总成本约为 3000 亿美元。

上述数据表明，由于医疗意识的提高、可支配收入的增加以及外科设施的各种发展，各国正在增加对医疗保健和相关设施的支出。因此，患有各种疾病的患者正在接受手术（一种更好、更快的治疗选择），这推动了全球手术粘合剂市场的增长。

与手术粘合剂相关的副作用和法律复杂性预计将阻碍市场增长

外科粘合剂对其可用性和安全性有一些限制，包括过敏反应、清创和皮肤感染。它也被 FDA 归类为 II 类，在印度的药品和化妆品法案 (1940) 下被归类为 B 类，并且有点风险，需要进行临床试验并导致进一步的法律并发症。这些材料的安全性、质量和性能需要出于公共卫生目的进行严格评估，因此需要遵守复杂而严格的附属机构规定。因此，这些因素阻碍了外科粘合剂市场的增长。

行业分析

全球外科粘合剂市场基于波特五力、监管分析、供应链分析和定价分析等各种行业因素对市场进行了深入分析。

细分分析

氰基丙烯酸酯部分预计将在全球外科粘合剂市场占有最大的市场份额

全球外科粘合剂市场按纤维蛋白、胶原蛋白、明胶、氰基丙烯酸酯、聚合物水凝胶和聚氨酯粘合剂进行细分。氰基丙烯酸酯部分占据最大的市场份额。氰基丙烯酸酯是一种粘性物质，存在于许多类型的粘合剂中。摄入该物质或与皮肤接触会导致中毒。激活涂药器，将氰基丙烯酸酯粘合剂涂在潮湿的组织上，然后发生聚合反应。我们氰基丙烯酸酯设备的一个特点是在聚合开始时仅产生少量热量。因此，您不会体验到其他公司产品中的刺痛感或刺痛感。

氰基丙烯酸酯粘合剂具有生物相容性，不需要去除，因为它们会在伤口癒合过程中从皮肤上自然脱落。氰基丙烯酸酯的特性，即与皮肤表面粘合的快速固化、高强度聚合物，具有柔韧性、耐用性、防水性和凝固时的透明性，使氰基丙烯酸酯成为伤口闭合和皮肤屏障产品的理想选择。我正在製作东西。氰基丙烯酸酯可以非侵入性地闭合伤口，并且比传统的伤口闭合方法对患者的侵入性更小。常用于腹腔镜切口闭合，比纤维蛋白密封剂或缝合线强得多。氰基丙烯酸酯防水、柔韧且不需要伤口敷料。

在预测期内，纤维蛋白胶领域预计将出现积极的市场增长。纤维蛋白胶是一种源自人类和动物（牛）血液製品的外科粘合剂。纤维蛋白密封剂的成分在应用时相互作用，形成由纤维蛋白血液蛋白製成的凝块。纤维蛋白密封剂在心血管手术、肺部手术、硬脑膜闭合（覆盖大脑和脊髓的纤维膜）中有效，并可用于闭合脾臟和肝臟的撕裂伤。

纤维蛋白密封剂还用于止血过程，以控製手术期间和手术后的出血，使其成为纤维蛋白密封剂的市场领导者之一。纤维蛋白封闭剂由纤维蛋白原和凝血□组成，在严重出血时的止血过程中起重要作用。 .纤维蛋白密封剂是 FDA 批准用于临床的唯一一种商业可用材料，可用作止血剂和粘合剂。据说纤维蛋白密封剂是世界上使用最多的止血剂。

此外，市场还根据心血管外科、骨科外科、普通外科、整容外科、肺外科、中枢神经外科等进行细分。心血管外科拥有最大的市场份额。疾病发病率的上升相应地推动了手术数量的增加，从而促进了全球手术中的手术粘合剂，主要是心血管手术。多年来，这一直是大多数提供外科服务的医疗中心的标准程序。不断增加的范围和数量的外科手术在该领域处于领先地位。

世界人口日益老龄化是该领域的主要驱动力之一。根据世卫组织的数据，2015 年至 2050 年间，世界老年人口预计将翻一番，从 12.0% 增加到 22.0%。老年人群的血管功能障碍和先天性畸形的增加预计将推动市场。此外，缺乏运动和不健康的生活方式也会增加心血管疾病的发病率。

根据美国心臟协会的调查，2016 年美国死于心血管疾病的人数超过 8,000 人。已证实这些疾病夺走的生命比慢性下呼吸道疾病和癌症加起来还要多。每天约有 2,300 名美国人死于心血管疾病，平均每 38 秒就有 1 人死亡。这些因素将推动该细分市场的增长。

预计整容手术部门在预测期内将见证积极的市场增长。这是由于在整容手术和烧伤手术中越来越多地使用手术粘合剂。随着更多的面部整容手术、更多的皮肤损伤病例、更高的烧伤发生率以及全球更多接受乳房切除术和乳房重建手术的乳腺癌患者，预计这一数字将进一步上升。预计这些因素将在预测期内推动市场增长。

区域分析

北美占全球外科粘合剂市场的最大市场份额。

按地区划分，全球外科粘合剂市场分为北美、南美、欧洲、亚太地区、中东和非洲。在所有地区中，北美在全球外科粘合剂市场中占主导地位，预计在预测期内将以最高的复合年增长率增长。预计北美仍将是未来几年增长率最高的外科粘合剂市场。增长的动力来自于对医用粘合剂研发投资的增加及其在该地区进行的各种外科手术中的应用。根据 2020 年心脏病和中风统计情况说明书，估计美国每年至少有 40,000 名婴儿受到先天性心脏病的影响。其中，大约 25% 或 2.4（每 1,000 名活产婴儿）需要在出生后的第一年内接受治疗。此外，美国对整容手术的需求和关注度不断提高，以及对预防和矫正治疗的认识不断提高，也推动了该地区的市场增长。

亚太地区预计将占据第三大市场份额，因为其患者人数众多、熟练技术人员相对便宜，以及有利于快速产品批准的监管框架。此外，印度、中国和马来西亚蓬勃发展的医疗旅游业预计将推动对手术粘合剂的需求。

竞争格局

由于存在多个国际和国内市场，全球外科粘合剂市场竞争激烈。产品多样化、货币化和机会使市场更具竞争力。B. Braun Melsungen AG、Baxter International Inc、Advanced Medical Solutions Group PLC、CR Bard Inc、Cardinal Health Inc、CryoLife Inc、Integra Lifesciences Holdings Corporation、Cothera Medical Inc、Takeda Pharmaceutical Company Limited、Johnson &Johnson、Medtronic PLC具有市场份额的主要市场参与者。主要参与者正在利用产品开发、新产品发布、市场扩张和产品多元化战略来保持其市场地位。

公司通过合作、合併、战略伙伴关係和收购来扩大其影响力并满足全球对外科粘合剂不断增长的需求。例如：

  • 2021 年 7 月，Baxter收购了 PerClot 多醣止血系统，通过主动和被动止血解决方案增加了其先进的手术产品组合。
  • 2019 年 6 月，Technion-Israel Institute of Technology 的研究人员宣布，他们开发出一种无毒、可生物降解且具有柔韧性的新型外科粘合剂。这种新产品适用于内部和外部手术。儘管它已成为外科缝合器和缝合线的可靠替代品，但外科粘合剂通常仅在体外使用。

值得关注的主要公司

B. Braun Melsungen AG：

描述 简介 生产医疗器械和药品的德国公司。公司总部位于德国梅尔松根，成立于 1839 年。它在大约 60 个国家提供服务，拥有大约 63,000 名员工。约5,000种保健品。

产品介绍

Histoacrylic 是一种组织粘合剂，含有单体 2-氰基丙烯酸正丁酯，在与组织液接触后立即聚合。它有两种颜色：适合涂抹于面部的半透明和易于控制涂抹量的蓝色。

重大发展。2020 年 6 月，B. Brown 宣布扩大其针对医疗保健解决方案的测试能力组合。

全球外科粘合剂市场报告提供了大约 45 多个市场数据表、40 多个数字和 180 页的组成。

目录

第一章 调查方法和范围

  • 调查方法
  • 调查目的和范围

第二章市场定义和概述

第三章执行摘要

第四章市场动态

  • 市场影响因素
    • 促进者
      • 交通事故数量增加
      • 增加外科手术
    • 抑製剂
      • 与手术胶相关的副作用
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析

第 6 章 按产品分类

  • 天然粘合剂
    • 毛布林
    • 明胶
    • 胶原
  • 合成粘合剂
    • 氰基丙烯酸酯
    • 水凝胶
    • 聚氨酯系统

第 7 章 适应症/效果

  • 止血
  • 组织阻滞
  • 组织工程

第 8 章 按用途

  • 心血管外科
  • 普通外科
  • 神经外科
  • 呼吸
  • 整形外科
  • 骨科
  • 眼科
  • 伤口处理
  • 其他

第 9 章最终用户

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章 竞争格局

  • 竞争情景
  • 市场定位/市场份额分析
  • 併购分析

第十二章公司简介

  • B. Braun Melsungen AG
    • 公司简介
    • 产品组合和描述
    • 主要发展状况
    • 财务概览
  • Baxter International Inc.
  • Advanced Medical Solutions Group PLC
  • C. R. Bard Inc
  • Cardinal Health Inc.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corporation
  • Cohera Medical Inc.
  • Takeda Pharmaceutical Company Limited.
  • Medtronic PLC.

第 13 章全球外科粘合剂市场-DataM

简介目录
Product Code: DMHOS2605

Market Overview

Surgical Glue Market size was valued US$ 5.28 billion in 2021 and is estimated to reach US$ 9.13 billion by 2029, growing at a CAGR of 7.64% during the forecast period (2022-2029).

Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop bodily fluids flow. Advancements in the surgical glue market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to surgical glue's favorable biological and physical properties, more surgeons are using this technique to seal wounds. Surgical glue is derived from several natural biopolymers, including gelatin, collagen, chitosan, albumin, and fibrin.

Market Dynamics

The market growth is driven by various factors such as rise in the number of surgical procedures and burn cases and increasing incidences of road accidents globally and rising health awareness.

Increasing number of surgical procedures and rising traumatic injuries are expected to drive market growth.

The rising number of traumatic injuries drives the market. The market growth is also majorly driven by the rise in the number of surgical procedures and burn cases and increasing incidences of road accidents globally. The rising health awareness and high prevalence of diseases (such as skin diseases, cancer, heart diseases, and respiratory diseases) have increased the opportunities for surgeries.

According to the World Health Organization (WHO) 2020 report, estimates approximately 1.35 million people die each year due to road traffic crashes. 20 to 50 million people suffer from non-fatal injuries, with many incurring a disability resulting from their injury. 93% of the world's fatalities on the roads occur in low and middle-income countries, even though they have approximately 60% of the world's vehicles. Even within high-income countries, individuals from lower socioeconomic backgrounds are more likely to be involved in road traffic crashes. Thus, the rising prevalence of diseases along with road injury cases is expected to drive the market.

Additionally, there are innumerable accessibility and availability of these devices across the globe, which is one of the major reasons for the growth of the surgical glue market. It has been observed that the citizens of both developed and developing countries are extensively spending on healthcare services due to the increasing disposable income of the residents of those countries and increasing health issues.

According to a recent study published by the Centers for Disease Control and Prevention (CDC), it has been established that the total expenditure on healthcare services in the U.S. has projected towards a total of $3.9 trillion. Moreover, according to a report furnished by the U.K. Office for National Statistics (ONS), the U.K.'s total healthcare expenditure accounted for approximately $300 billion in the recent past.

The abovementioned data indicate that countries are increasingly spending on healthcare and related facilities owing to rising medical awareness, growth in disposable income, and various developments in surgical facilities. Thus, patients suffering from various diseases are going for surgeries (better and quick treatment options), which drives the global surgical glue market growth.

Side effects associated with surgical glue and legal complexities expected to hamper the growth of market

Surgical glue has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. Besides, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the surgical glue market.

Industry Analysis

The global surgical glue market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis.

Segment Analysis

Cyanoacrylates segment is expected to hold the largest market share in global surgical glue market

The global surgical glue market is segmented on fibrin, collagen, gelatin, cyanoacrylate, polymeric hydrogel, and urethane-based adhesive. The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many types of glue. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue, the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low heat level is generated when this polymerization starts. Consequently, the patient does not experience the stinging or burning sensation that occurs with some competitor products.

Cyanoacrylate glue is biocompatible and does not need removal as it naturally slough off the skin as part of the natural wound healing process. Cyanoacrylate properties, namely fast-setting, high tensile strength polymers that bind with the skin's surface and are flexible, durable, waterproof, and transparent on the setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and enhance the patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible, and require no dressing on the wound.

The fibrin glue segment is expected to have positive market growth in the forecast period. Fibrin glue is a type of surgical adhesive derived from both human and animal (bovine) blood products. Ingredients in the fibrin sealant interact during application to form a clot made from fibrin's blood protein. Fibrin sealants are effective for cardiovascular surgery, lung surgery, and closure of the Dural (a fibrous membrane covering the brain and spinal cord) and can be used to close spleen and liver lacerations.

Fibrin sealant is also used in hemostasis processes to control bleeding during and after surgical procedures, one of the leading fibrin sealants market trends. Fibrin sealant comprises fibrinogen and thrombin, which play a vital role in the hemostasis process during severe bleeding. . Fibrin sealant is the only commercially available FDA-approved material for clinical use a hemostat sealant and adhesive. Fibrin sealants are referred to as the most adopted hemostats worldwide.

Further, the market is also classified based on cardiovascular surgery, orthopedic surgery, general surgery, cosmetic surgery, pulmonary surgery, central nervous system surgery, and others. The cardiovascular surgery segment is held the largest market share. The rise in the incidence of diseases correspondingly drives the number of surgical procedures performed, thereby boosting surgical glues in surgeries and, mainly, cardiovascular procedures globally. It has been a standard procedure in most medical centers providing surgical services for several years. Both the range and the number of surgical procedures performed are constantly increasing, driving the segment.

The globally increasing aging population is one of the major drivers of this segment. According to WHO, the world's geriatric population is expected to nearly double from 12.0% to 22.0% between 2015 and 2050. The market is expected to be driven by a vascular malfunction in the geriatric population and a rise in congenital disabilities. Furthermore, physical inactivity and an unhealthy lifestyle are also increasing the incidence of cardiovascular conditions.

According to the American Heart Association Research, cardiovascular diseases accounted for more than 8 lakh deaths in the U.S. in 2016. It has been observed that these diseases claim more lives than chronic lower respiratory disease and cancer combined. Approximately 2,300 Americans die due to cardiovascular diseases each day, an average of one death every 38 seconds. This factor will drive the growth of the segment.

The cosmetic surgery segment is expected to have positive market growth in the forecast period. This is due to the increasing adoption of surgical glue for cosmetic procedures and burns treatment surgeries. It is further set to increase with the increasing number of facial cosmetic surgeries, increasing cases of skin injuries, growing incidence of burn injuries, and an increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures across the globe. This factor will drive the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global surgical glue market

By region, the global surgical glue market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global surgical glue market and is expected to grow at the highest CAGR during the forecast period. North America is anticipated to continue being the largest-growing surgical glue market in the coming years. The factors contributing to the growth include the increasing investments in R&D of medical adhesives and their several applications in different surgeries performed in the region. As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25%, or 2.4 (per 1,000 live births), require treatment in the first year of life. Moreover, the increasing demand for and focus on cosmetic surgery and its growing awareness of preventative and corrective treatment in the USA are driving the growth of the market in this region.

The Asia-Pacific region is expected to have the third-largest share due to a large patient pool, availability of skilled technicians at a comparatively lower price, and a defined regulatory framework favoring expedited product approvals. Furthermore, the booming medical tourism industry in India, China, and Malaysia is expected to boost demand for surgical glue.

Competitive Landscape

The global surgical glue market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition B. Braun Melsungen AG, Baxter International Inc., Advanced Medical Solutions Group PLC, C. R. Bard Inc., Cardinal Health Inc., CryoLife Inc., Integra Lifesciences Holdings Corporation, Cohera Medical Inc., Takeda Pharmaceutical Company Limited., and Johnson & Johnson, Medtronic PLC. are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies enter into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for surgical glue across the globe. For instance,

  • In Jul 2021, Baxter acquired PerClot polysaccharide hemostatic system to increase its advanced surgery portfolio with active and passive hemostatic solutions.
  • In June 2019, the research team at Technion - Israel Institute of Technology announced that they had developed a new surgical glue that is non-toxic, biodegradable, and flexible. The new product is compatible with both internal as well as external surgeries. Despite emerging as a reliable alternative for surgical staplers and sutures, surgical glue is typically used only for external applications.

Key Companies to Watch

B. Braun Melsungen AG:

Overview: B. Braun is German company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and founded in 1839. They provide services in around 60 countries that employees around 63,000 people. They have aroubd 5,000 variety of healthcare products.

Product Portfolio:

Histoacryl: It is a tissue adhesive which contains monomeric n-butyl-2-cyanoacrylate, that quickly polymerises in connection to tissue fluid. It can be found in two colours: translucent, that is specially designed for facial application and blue, that provides easy control over the amount applied.

Key Developments: In Jun 2020, B. Braun announced about extending its portfolio of healthcare solutions testing capabilities.

The global surgical glue market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Increasing Incidences of Road Accidents
      • 4.1.1.2. Growing Number of Surgical Procedures
    • 4.1.2. Restraints:
      • 4.1.2.1. Side Effects Associated with Surgical Glue
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Natural adhesive
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 6.2.3. Firbrin
    • 6.2.4. Gelatin
    • 6.2.5. Collagen
  • 6.3. Synthetic adhesive
    • 6.3.1. Cyanoacrylates
    • 6.3.2. Hydrogel
    • 6.3.3. Urethane based

7. By Indication

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Segment
    • 7.1.2. Market Attractiveness Index, By Indication Segment
  • 7.2. Hemostasis
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tissue Sealing
  • 7.4. Tissue Engineering

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular Surgery
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. General Surgery
  • 8.4. Neuro Surgery
  • 8.5. Pulmonary
  • 8.6. Plastic surgery
  • 8.7. Orthopedic
  • 8.8. Ophthalmology
  • 8.9. Wound Management
  • 8.10. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centres
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. The U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Developments
    • 12.1.4. Financial Overview
  • 12.2. Baxter International Inc.
  • 12.3. Advanced Medical Solutions Group PLC
  • 12.4. C. R. Bard Inc
  • 12.5. Cardinal Health Inc.
  • 12.6. CryoLife Inc.
  • 12.7. Integra LifeSciences Holdings Corporation
  • 12.8. Cohera Medical Inc.
  • 12.9. Takeda Pharmaceutical Company Limited.
  • 12.10. Medtronic PLC.

LIST NOT EXHAUSTIVE

13. Global Surgical Glue Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Method of Fixation
  • 13.3. Contact Us